question: Compared to placebo what was the result of evacetrapib (10–600 mg) on high-density lipoprotein-cholesterol (HDL-C)?
context: At the highest dose tested (600 mg), evacetrapib increased HDL-C by 86.8% (P < 0.001 vs placebo)